http://www.aktiencheck.de aktiencheck.de aktiencheck.de Fri, 17 Apr 2026 10:20:39 +0200 2 http://www.aktiencheck.de/forum/Kalytera_Therapeutics_vor_Phase_3_Tests-A3CSQG-t564654 http://www.aktiencheck.de/forum/Kalytera_Therapeutics_vor_Phase_3_Tests-A3CSQG-t564654 Graft-Versus-Host Disease (GVHD) market report, Key Market Competitors: Sanofi (France), Novartis AG (Switzerland), Neovii Biotech GmbH (Germany), Merck & Co., Inc. (US), Astellas Pharma Inc. (Japan), Soligenix, Inc. (US), Mesoblast Ltd. (Australia), Johnson & Johnson Services, Inc. (US), Mallinckrodft (US), ElsaLys Biotech SA (France), Incyte Corporation (US), Kiadis Pharma (Netherlands) and few among others. Key Developments in the Market: On 13th January 2017, Kalytera Therapeutics, Inc. announced that it acquired Talent Biotechs Ltd.which is an Israel based company evaluating the use of CBD to prevent and treat Graft versus Host Disease (“GvHD”). This agreement will strengthen Kalytera’s position as an emerging market leader in cannabidiol (“CBD”) pharmaceuticals. https://instanews247. [<a href="http://www.aktiencheck.de/forum/Kalytera_Therapeutics_vor_Phase_3_Tests-A3CSQG-t564654">mehr</a>] http://www.aktiencheck.de/forum/Mega_Volumen_drueben_von_ueber_20_mio_bisher-A3CSQG-t558553 http://www.aktiencheck.de/forum/Mega_Volumen_drueben_von_ueber_20_mio_bisher-A3CSQG-t558553 Mega Volumen drüben von über 20 mio bisher., Chart sieht auch gut aus.Dürften gute news anstehn.Hab mit mal paar Teile geholt. [<a href="http://www.aktiencheck.de/forum/Mega_Volumen_drueben_von_ueber_20_mio_bisher-A3CSQG-t558553">mehr</a>]